Lipopolysaccharide-Induced Leukocyte Lipid Body Formation In Vivo: Innate Immunity Elicited Intracellular Loci Involved in Eicosanoid Metabolism
Patrícia Pacheco(Georgia Institute of Technology), Patrı́cia T. Bozza(Fundação Oswaldo Cruz), Peter F. Weller(Beth Israel Deaconess Medical Center), Fernando A. Bozza(D’Or Institute for Research and Education), Rachel N. Gomes(Fundação Oswaldo Cruz), Hugo C. Castro‐Faria‐Neto(Fundação Oswaldo Cruz), Marcelo T. Bozza(Universidade Federal do Rio de Janeiro)
Cited by 153
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Lipid droplets: platforms with multiple functions in cancer hallmarks
|Cell Death and Disease|2020|530
Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
|The Lancet Respiratory Medicine|2021|527